MGRVX
Price
$50.47
Change
+$0.18 (+0.36%)
Updated
Oct 8 closing price
Net Assets
21.82B
RERBX
Price
$61.83
Change
+$0.49 (+0.80%)
Updated
Oct 8 closing price
Net Assets
137.54B
Interact to see
Advertisement

MGRVX vs RERBX

Header iconMGRVX vs RERBX Comparison
Open Charts MGRVX vs RERBXBanner chart's image
MFS International Growth R4
Price$50.47
Change+$0.18 (+0.36%)
VolumeN/A
Net Assets21.82B
American Funds EUPAC R2
Price$61.83
Change+$0.49 (+0.80%)
VolumeN/A
Net Assets137.54B
MGRVX vs RERBX Comparison Chart in %
View a ticker or compare two or three
VS
MGRVX vs. RERBX commentary
Oct 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MGRVX is a Buy and RERBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RERBX has more cash in the bank: 138B vs. MGRVX (21.8B). MGRVX pays higher dividends than RERBX: MGRVX (1.26) vs RERBX (0.24). MGRVX was incepted earlier than RERBX: MGRVX (17 years) vs RERBX (23 years). RERBX (1.56) is less costly to investors than MGRVX (0.85). RERBX is a more actively managed with annual turnover of: 35.00 vs. MGRVX (20.00). MGRVX has a lower initial minimum investment than RERBX: MGRVX (0) vs RERBX (250). RERBX annual gain was more profitable for investors over the last year : 10.25 vs. MGRVX (9.46). MGRVX return over 5 years is better than : 33.38 vs. RERBX (9.41).
MGRVXRERBXMGRVX / RERBX
Total Expense Ratio0.841.5654%
Annual Report Gross Expense Ratio0.851.5654%
Fund Existence17 years23 years-
Gain YTD21.41521.59399%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets21.8B138B16%
Annual Yield % from dividends1.260.24530%
Returns for 1 year9.4610.2592%
Returns for 3 years59.1347.60124%
Returns for 5 years33.389.41355%
Returns for 10 years111.8237.49298%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
STOK30.503.19
+11.68%
Stoke Therapeutics
AAME2.920.14
+5.22%
Atlantic American Corp
FIVE153.765.26
+3.54%
Five Below
QETAU10.84N/A
N/A
Quetta Acquisition Corp
TONX6.33-0.05
-0.71%
TON Strategy Company